Regulatory scrutiny around antipsychotic use in long-term care is increasing. Expectations tied to appropriate use, documentation, and gradual dose reduction (GDR) are becoming more defined—and less forgiving.

At the same time, updated clinical guidance is reinforcing the need to actively deprescribe psychotropic medications when appropriate—not just review them.

For operators and clinicians, this creates a clear reality: expectations are tightening from both sides.

What’s Expected Now

Communities are being asked to demonstrate not just awareness of best practices, but consistent execution. Antipsychotic use must be justified, regularly evaluated, and reduced when possible. That includes:

• Clear clinical rationale for use
• Documented non-pharmacologic interventions
• Ongoing monitoring and reassessment
• GDR attempts unless contraindicated

At the same time, deprescribing is no longer a passive concept. Clinical recommendations emphasize ongoing risk-benefit evaluation and intentional dose reduction when appropriate.

This is where many communities feel the strain—not in understanding expectations, but in aligning prescribers, staff, and documentation to meet them consistently.

Where Execution Actually Happens

This is where consultant pharmacists become essential.

Consultant pharmacists make deprescribing and GDR recommendations every day for psychotropic medications used in long-term care. They are continuously evaluating regimens, identifying opportunities to reduce or discontinue medications, and providing prescribers with recommendations to support appropriate use. They are not an added layer—they are the connective tissue between clinical guidance, regulatory expectations, and real-world prescribing. For facilities, they are often the most effective ally for facilities—bringing consistency, clinical insight, and follow-through to complex medication decisions.

From Expectation to Practice

Pressure around antipsychotic use is not easing. If anything, expectations will continue to tighten as clinical guidance and regulatory oversight align. Communities that stay ahead are not reacting at survey time. They are building consistent processes that support both appropriate prescribing and defensible documentation.

That includes:

• Routine interdisciplinary medication review
• Clear, consistent documentation
• Strong collaboration with prescribers and pharmacy
• Follow-through on deprescribing and GDR recommendations

In today’s environment, appropriate use of psychotropic medications is not just a clinical decision. It is an operational standard.